MAbSilico Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Employees
  • 14

Employees

  • Latest Deal Type
  • Debt

  • Latest Deal Amount
  • $234K

  • Investors
  • 3

MAbSilico General Information

Description

Developer of a computational platform designed to support antibody discovery and development. The company offers antibody characterization, optimization, and de novo design tools, along with software providing access to a proprietary database of patented antibodies linked to biophysical properties, enabling pharmaceutical and biotechnology companies to assess, optimize, and design antibodies.

Contact Information

Website
www.mabsilico.com
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • 1 impasse du Palais
  • 37000 Tours
  • France
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Biotechnology
Vertical(s)
Life Sciences
Corporate Office
  • 1 impasse du Palais
  • 37000 Tours
  • France

MAbSilico Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

MAbSilico Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Debt - General 21-May-2026 $234K Completed Generating Revenue
7. Debt - General Completed Generating Revenue
6. Grant 31-Jul-2025 Completed Generating Revenue
5. Accelerator/Incubator 30-Sep-2024 Completed Generating Revenue
4. Grant 21-Sep-2023 Completed Generating Revenue
3. Accelerator/Incubator 21-Sep-2023 Completed Generating Revenue
2. Grant 30-Sep-2022 $992K Completed Generating Revenue
1. Grant 17-Dec-2019 $111K Completed Generating Revenue
To view MAbSilico’s complete valuation and funding history, request access »

MAbSilico Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a computational platform designed to support antibody discovery and development. The company offers antibod
Discovery Tools (Healthcare)
Tours, France
14 As of 2026

Surfside, FL
 

San Francisco, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

MAbSilico Competitors (5)

One of MAbSilico’s 5 competitors is EVQLV, a Venture Capital-Backed company based in Surfside, FL.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
EVQLV Venture Capital-Backed Surfside, FL
Chai Discovery Venture Capital-Backed San Francisco, CA
BigHat Biosciences Venture Capital-Backed San Mateo, CA
Absci Formerly VC-backed Vancouver, WA
Isomorphic Labs Venture Capital-Backed London, United Kingdom
You’re viewing 5 of 5 competitors. Get the full list »

MAbSilico Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

MAbSilico Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
BioLabs Incubator Accelerator/Incubator
European Union Government
Bpifrance Sovereign Wealth Fund
To view MAbSilico’s complete investors history, request access »

Ready to get started?

Request a free trial

MAbSilico FAQs

  • When was MAbSilico founded?

    MAbSilico was founded in 2017.

  • Where is MAbSilico headquartered?

    MAbSilico is headquartered in Tours, France.

  • What is the size of MAbSilico?

    MAbSilico has 14 total employees.

  • What industry is MAbSilico in?

    MAbSilico’s primary industry is Discovery Tools (Healthcare).

  • Is MAbSilico a private or public company?

    MAbSilico is a Private company.

  • What is MAbSilico’s current revenue?

    The current revenue for MAbSilico is .

  • How much funding has MAbSilico raised over time?

    MAbSilico has raised $813K.

  • Who are MAbSilico’s investors?

    BioLabs Incubator, European Union, and Bpifrance have invested in MAbSilico.

  • Who are MAbSilico’s competitors?

    EVQLV, Chai Discovery, BigHat Biosciences, Absci, and Isomorphic Labs are competitors of MAbSilico.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process